SCHEMBL4863760

SCHEMBL4863760

COCCOCCON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11885389 1.00 CA2 (0.41)
SCHEMBL3072771 1.00 CA2 (0.41)
SCHEMBL16438222 1.00 CA2 (0.41)
SCHEMBL10196037 1.00 CA2 (0.41)
SCHEMBL6555701 1.00 CA2 (0.41)
SCHEMBL317775 0.90
SCHEMBL30130365 0.88 CA2 (0.34)
Hydrochloric Acid SCHEMBL1781746 0.87
SCHEMBL28880086 0.85 CA2 (0.34)
SCHEMBL23647292 0.83 CA2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4694874-A2 GPX4 INHIBITORS AND SENOLYTIC COMPOUNDS AND USES THEREOF Rubedo Life Sciences, Inc. (US) 2026-02-18 EP disclosed
US-20260007689-A1 GPX4 Inhibitors and Senolytic Compounds and Uses Thereof RUBEDO LIFE SCIENCES INC (US) 2026-01-08 US disclosed
US-12485132-B2 GPX4 inhibitors and senolytic compounds and uses thereof Rubedo Life Sciences, Inc. (US) 2025-12-02 US disclosed
US-20250319109-A1 GPX4 Inhibitors and Senolytic Compounds and Uses Thereof RUBEDO LIFE SCIENCES INC (US) 2025-10-16 US disclosed
US-20240408124-A1 GPX4 Inhibitors and Senolytic Compounds and Uses Thereof Rubedo Life Sciences, Inc. 2024-12-12 US disclosed
WO-2024249613-A2 GPX4 INHIBITORS AND SENOLYTIC COMPOUNDS AND USES THEREOF Rubedo Life Sciences, Inc. (US) 2024-12-05 WO disclosed
EP-4397677-A1 HUMAN INTERLEUKIN 2-POLYETHYLENE GLYCOL CONJUGATE AND USE THEREOF Novocodex Biopharmaceuticals Co., Ltd. (CN) 2024-07-10 EP disclosed
EP-3604305-A1 NOVEL PYRIDONE CARBOXYLIC ACID DERIVATIVE OR SALT THEREOF Wakunaga Pharmaceutical Co., Ltd. (JP) 2020-02-05 EP disclosed
US-20170368193-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-12-28 US disclosed
US-20170340746-A1 PEGYLATED CARFILZOMIB COMPOUNDS AMGEN INC. 2017-11-30 US disclosed
US-20110054152-A1 Hydroxyalkyl Starch Derivatives FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2011-03-03 US disclosed
US-20080206182-A1 Conjugates of a Polymer and a Protein Linked by an Oxime Group FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2008-08-28 US disclosed
US-7411001-B2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2008-08-12 US disclosed
US-7411001-B2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2008-08-12 US disclosed
WO-2007084413-A2 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2007-07-26 WO disclosed
US-6960614-B2 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2005-11-01 US disclosed
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2005-08-11 US disclosed
US-20040054172-A1 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2004-03-18 US disclosed
EP-1301472-A2 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER-LAMBERT COMPANY (US) 2003-04-16 EP disclosed
WO-2002006213-A2 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER-LAMBERT COMPANY (US) 2002-01-24 WO disclosed